Fixed Drug Eruption with Pigmentation Induced by Etoricoxib: A Case Report
DOI:
https://doi.org/10.17533/udea.iatreia.280Keywords:
Drug Eruptions, Erythema, EtoricoxibAbstract
Fixed drug eruption with pigmentation is characterized by the appearance of erythematous or bullous lesions following the ingestion of certain medications. We present the case of a 23-year-old male patient who sought medical attention due to painful and pruritic lesions on the ventral surface of the penis, encompassing the glans, frenulum, and prepuce. The patient's history revealed prior consumption of etoricoxib and previous occurrences of similar lesions in the same region. After prescribing a topical corticosteroid for 5 days, the patient returned for follow-up, demonstrating clinical improvement with residual hyperpigmentation. Based on the history of etoricoxib use, previous episodes, and the characteristics of the lesions, a diagnosis of fixed drug eruption with pigmentation was established.
Downloads
References
(1) Patel S, John AM, Handler MZ, Schwartz RA. Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption. Am J Clin Dermatol [Internet]. 2020;21(3):393-9. https://doi.org/10.1007/s40257-020-00505-3
(2) Lipowicz S, Sekula P, Ingen-Housz-Oro S, Liss Y, Sassolas B, Dunant A, et al. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol [Internet]. 2013;168(4):726-32. https://doi.org/10.1111/bjd.12133
(3) Montazer F, Jahani-Amiri K, Mofarrah R, Ahmadi A, Nouripour B, Mofarrah R. A first case of fixed drug eruption due to Tamsulosin. J Cosmet Dermatol [Internet]. 2020;19(5):1143-5. https://doi.org/10.1111/jocd.13125
(4) Martínez-Antón MD, Galán-Gimeno C, Sánchez de Vicente J, Jáuregui-Presa I, Gamboa-Setién PM. Etoricoxib-induced fixed drug eruption: Report of seven cases. Contact Dermatitis [Internet]. 2021;84(3):192-5. https://doi.org/10.1111/cod.13659
(5) Khan S, Andrews KL, Chin-Dusting JPF. Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory? Int J Mol Sci [Internet]. 2019;20(17):4262. https://doi.org/10.3390/ijms20174262
(6) Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol [Internet]. 2017;89:218-35. https://doi.org/10.1016/j.jclinepi.2017.04.026
(7) Jung JW, Cho SH, Kim KH, Min KU, Kang HR. Clinical Features of Fixed Drug Eruption at a Tertiary Hospital in Korea. Allergy Asthma Immunol Res [Internet]. 2014;6(5):415-20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161682/
(8) Anderson HJ, Lee JB. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption. Medicina (Mex) [Internet]. 2021;57(9):925.
https://doi.org/10.3390/medicina57090925
(9) World Health Organization. VigiAccess [Internet]. [Consultado 09 dic 2023]. Available from: https://www.vigiaccess.org/#/
(10) Patell RD, Dosi RV, Shah PC, Joshi HS. Widespread bullous fixed drug eruption. BMJ Case Rep [Internet]. 2014;2014:bcr2013200584. https://doi.org/10.1136/bcr-2013-200584
(11) Zaouak A, Ben-Salem F, Ben-Jannet S, Hammami H, Fenniche S. Bullous fixed drug eruption: A potential diagnostic pitfall: a study of 18 cases. Therapies [Internet]. 2019;74(5):527-30. https://doi.org/10.1016/j.therap.2019.01.009
(12) Tripathy R, Pattnaik KP, Dehury S, Patro S, Mohanty P, Sahoo SS, et al. Cutaneous adverse drug reactions with fixed-dose combinations: Special reference to self-medication and preventability. Indian J Pharmacol [Internet]. 2018;50(4):192-6. https://doi.org/10.4103/ijp.IJP_760_16
(13) Heng YK, Yew YW, Lim DSY, Lim YL. An update of fixed drug eruptions in Singapore. J Eur Acad Dermatol Venereol [Internet]. 2015;29(8):1539-44. https://doi.org/10.1111/jdv.12919
(14) Al Masri D, Fleifel M, Hirbli K. Fixed Drug Eruption Secondary to Four Anti-diabetic Medications: An Unusual Case of Polysensitivity. Cureus [Internet]. 2021;13(10):e18599. https://doi.org/10.7759/cureus.18599
(15) Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther [Internet]. 1981;30(2):239-45. https://doi.org/10.1038/clpt.1981.154
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Iatreia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.
